Jonathan Douxfils

87PUBLICATIONS
106CO-AUTHORS
Toxicology (incl. clinical toxicology)Consumer-oriented product or service developmentRespiratory diseasesObstetrics and gynaecologyMedical biochemistry - nucleic acids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (87)

|Jul 28, 2026
Statins Safety Signals: From Precautions to Proportionate Evidence-Based Labeling.

|May 15, 2026
Potential risk of neoplasms with fezolinetant: clinical evidence, mechanisms, and post-marketing implications.

|Apr 16, 2026
Device-Induced Thrombosis in Blood-Contacting Medical Devices: Mechanisms and Emerging Prevention Strategies.

|Feb 02, 2026
Venous Thromboembolism Risk Associated With Relugolix-estradiol-norethisterone Acetate Combination Therapy.

Jonathan Douxfils, Marie Didembourg, Lorraine Maitrot-Mantelet

|Jan 12, 2026
Frequently Reported Blood Biomarkers in Sarcopenia Clinical Trials: A Systematic Review and Meta-Analysis.

Emma Calluy, Yveline Malrechauffé, Emma Boretti

|Sep 27, 2025
Critical Considerations in the Interpretation of Bone Turnover Marker Data in Hormonal Contraceptive Users. Comment on Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. Pharmaceuticals 2025, 18, 61.

Jonathan Douxfils, Jean-Michel Foidart

Pageof 15

Frequent Collaborators

19 joint publications

François Mullier

13 joint publications

Constant Gillot

11 joint publications

Laure Morimont

8 joint publications

Michael Hardy